It has been further demonstrated that PD-1+CD39+CD8+ TEX are tumor specific, are associated with good prognosis in head and neck cancer patients, and predict response to checkpoint blockade in lung cancer patients (21, 22). The gene discussed is ENTPD1; the disease is neoplasm.